DDInter397 DDInter1180
Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. It inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites. It is used for the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Clidinium {u} (Compound) resembles {v} (Compound) Diphenylpyraline
Clidinium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Mepenzolate
Clidinium {u} (Compound) binds {v} (Gene) CHRM3
Clidinium {u} (Compound) is included by {v} (Pharmacologic Class) Cholinergic Antagonists
Clidinium {u} may cause a minor interaction that can limit clinical effects when taken with {v} Bendroflumethiazide
Clidinium {u} may cause a minor interaction that can limit clinical effects when taken with {v} Hydrochlorothiazide
Clidinium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Hyoscyamine
Clidinium {u} may lead to a major life threatening interaction when taken with {v} Potassium chloride
Clidinium {u} may lead to a major life threatening interaction when taken with {v} Zonisamide
Clidinium {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Darifenacin
Clidinium (Compound) resembles Diphenylpyraline (Compound)
Clidinium may cause a moderate interaction that could exacerbate diseases when taken with Mepenzolate
Clidinium (Compound) binds CHRM3 (Gene)
Clidinium (Compound) is included by Cholinergic Antagonists (Pharmacologic Class)
Clidinium may cause a minor interaction that can limit clinical effects when taken with Bendroflumethiazide
Clidinium may cause a minor interaction that can limit clinical effects when taken with Hydrochlorothiazide
Clidinium may cause a moderate interaction that could exacerbate diseases when taken with Hyoscyamine
Clidinium may lead to a major life threatening interaction when taken with Potassium chloride
Clidinium may lead to a major life threatening interaction when taken with Zonisamide
Clidinium (Compound) resembles Darifenacin (Compound) and Clidinium may cause a moderate interaction that could exacerbate diseases when taken with Darifenacin